510(k) · Cleared
ClearedLasertx - Diode Laser & Delivery System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Prosurg, Inc. · GEX Powered Laser Surgical Instrument
Cleared on Apr 5, 2006 as substantially equivalent to K032864 (Biolitec, Inc., 2004) after a 55-day review. Its family tree reaches back 1 generation to 2004.
- Decided
- Apr 5, 2006
- Review
- 55 days
- Class
- Class II
- Product code
- GEX
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K032864 (2004). No later device cites it as a predicate yet.
- Root · 1 generation backK032864 Ceralas D 810 Diode Laser System, Model D15Biolitec, Inc. · 2004
- This deviceK060326 Lasertx - Diode Laser & Delivery SystemProsurg, Inc. · 2006
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K032864 | Ceralas D 810 Diode Laser System, Model D15 | Biolitec, Inc. | 2004 | — |
| 0 (this device) | K060326 | Lasertx - Diode Laser & Delivery System | Prosurg, Inc. | 2006 | — |
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K032864 | Ceralas D 810 Diode Laser System, Model D15Summary page 3…l indications for use please refer to attachment. (Additional Indications, identical to predicated device cleared by FDA under 510K application f K032864) Prescription Use v/ Over-The-Counter Use (Part 21 CFR 801 Subpart… | 2004 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- 3 other devices also cite its predicate K032864.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The LaserTx Diode Laser System is intended for delivery of laser light to soft tissue in contact or non contact mode during surgical procedures, including via endoscopes, introducers, or cathetrs. The LaserTx laser system is generally indicated for incision, excision Vaporization, ablation, henostatis or coagulation of soft tissue in Ear, Noew and Throat and Oral surgery (Otolaryngology), Dental Procedures, Arthroscopy Gastroenterology, General Surgery…
Read the full statement (788 words)
The LaserTx Diode Laser System is intended for delivery of laser light to soft tissue in contact or non contact mode during surgical procedures, including via endoscopes, introducers, or cathetrs. The LaserTx laser system is generally indicated for incision, excision Vaporization, ablation, henostatis or coagulation of soft tissue in Ear, Noew and Throat and Oral surgery (Otolaryngology), Dental Procedures, Arthroscopy Gastroenterology, General Surgery, Dermatology Plastic surgery, Podiatry, Urology, Gynecology, Neurosurgery (Peripheral nervous system) Pulmonary surgery and cardiothoracic surgery. The LaserTx Diode laser system can be used with fiber optic laser delivery devices and photosensitizing agents & chromophores to enabace target tissue effects and photo selective application during surgical procedures. The LaserTx Diode Laser system is indicated for incision, excision, vaporization, bemostatis coagulation, ablation of soft tissue, tumors, strictures, obstructions in body organs including urethra, bladder, prostate, uterus, breast, stomach, colon, abdomen, veins ling, brain. ear, nose throat etc. For additional indications for use please refer to attachment. (Additional Indications, identical to predicated device cleared by FDA under 510K application f K032864)
The device is specifically indicated for use as follows:
Ear, Nose and Throat and Oral Sirnewy (Otolaryn.9ologY)
Heinostasis, incision, excision, ablation, coagulation, and vaporization of tissue from the ear, vose, throat and adjacent areas including soft tissue in the oral cavity. Examples include:
• Removal of benign lesions forom the ear, nose and throat
• Excision and vaporization of vocal cord nodules and polyps
• Incision and excision of carcinoma in situ
• Ablation and vaporization of hyperkeratosis
• Excision of carcinoma of the larynx
• Laryngeal papillomertoiny
• Excision and vaporization of herpes simplex I and II
• Neck dissection
Arthroscopy
Ijenostasis, incision, excision, coagulation, vaporization and ablation of joint tissues during arthrosmopic surgery. Examples inchude:
• Mertisectomy
• Synoveactomy
• Chondromalacia
Gastroenterology,
Hemostasis, incision, excision, ablation, coagulation and vaporization of tissue in the upper and. lower gastrointestinal tracts. and also with endoscapic procedures. Examples include:
• Hemostasis of upper and lower GI bleeding-
• Excision and vaporization of7 colorectal caip6n~
• Excision of polyps
Genera] Surgery, Dermatology, Plastic Surgery and Podiatry
Excision, ablation, vaporization and photocoagulationaof skin lesions, hemostasis, incision, excision, vaporization, ablation and debulking of soft tissue, abdominal, rectaL, skin, fat or muscle tissue and dermabrasion. Examples include:
Matrixectoiny
•Excision of neuromas
•Excision of periurngual and subungual warts
•Excision of plantar warts
•Excision of Iceloids
• Uver resection
• Excision of cutaneous lesions
• lHemorrhoidectomy
• AppendectomY
• Debridemnent of decubitus ulcers
• Hepatobiliary tumors
• Mastectomny
• Dermabrasian
• Vaporization and horneostasis of capillary hemnangioma
• Excision, vaporization and hemostasis of abdominal tumors
• Excision, vaporization and hemlOstasis of rectal pathology
• Pilonidal cystectomy
• Herniorapphw
• Adhesiolysis
• Parathyzoidectorny
• Laparoscopic cholecystectomy
• Thyroidectomy
• Resection of organs
• Debridemenat of wounds
• Fhototcaagulation of teleangectasia of the legs and face
• Photocoagulation of vascular lesions of the face and extremities-
• EndovascuLar coagulation of the greater saphenous vein of the thigh in patients with superficial vein reflux.
• Treatment of reticular veins and branch varicosities
Urology
Excision, vaporization, incision, coagulation, ablation and horneosqtasis of urolagical tissues. Examples include:
• Vaporization of urethral tumors
• Release of urethral stricture
• Removal of bladder neck obstruction
• Excision and vaporization of condyloma
• Lesions of external genitalia
Gynecology
Ablation, excision, incision, coagulation, hemostasis and vaporization of gynecological tissue, Examples include:
• Endometrial ablation
• Excision or vaporization of condylomata acuminata
• Vaporization of cervical intraepithelial ncaplasia
• Cervical conization
• Menorrhagia
Neurosurgery
Vaporization, coagulation, excision, incision, ablation and hemostasis of soft tissue. Examples include: homeostasis in conjunction with menigiomas
Cardiac Surgery
Hemostasis and coagulation of soft tssue, including cardiac tissue.
Pulmonary Surgery
HFemostasis, vaporization, coagulation, incision, excision and ablation of soft tissue in the pulmonary system. Examples include:
Tracheobroachial malignancy or stricture
Benign and malignant pulmonary obstruction
Endoscopic pulmonary applications
Dental Applications
Indicated for the following applications on intraoral and extraoral soft tissue (including marginal and interdental gingival and epithelial lining of free gingival): frenectomy, frenotomy, biopsy, operculectomy, implant recovery, gingivectomy, gingivoplasty, gingival troughing, crown lengthening, hemostasis of donor site, removal of granulation tissue, laser assisted flap surgery, debridement of diseased epithelial lining, incisions and draining of abscesses, tissue retraction for impressions, papillectomy, vestibuloplasy, excision of lesions, exposure of unerupted/partially erupted teeth, leukoplakia, removal of hyperplastic tissues, treatment of aphthous ulcers and sulcular debridement (removal of diseased or inflamed soft tissue in the periodontal pocket), pulpotomy, pulpotomy as an adjunct to root canal therapy and light activation of bleaching materials for teeth whitening.
Endovenous Occlusion of the Greater Saphenous Vein in Patients with Superficial Vein Reflux
Indicated for use with the ELVes Procedure Kit in the endovascular coagulation of the Greater Saphenous Vein (GSV) of the thigh in patients with Superficial Vein Reflux.
Indications for use as stated in the FDA 510(k) statement.
https://510kreport.com/device/K060326 · printed Nov 6, 2026
Cite this page
510(k) Report. “K060326: Lasertx - Diode Laser & Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K060326
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026